Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|
| Turnover | -0.44%117.29M | -2.28%245.49M | -3.23%117.81M | 20.76%251.22M | --121.74M | 10.28%208.03M | --188.64M |
| Operating income | -0.44%117.29M | -2.28%245.49M | -3.23%117.81M | 20.76%251.22M | 121.74M | 10.28%208.03M | 188.64M |
| Cost of sales | -14.03%-34.65M | 3.57%-63.43M | 7.27%-30.39M | -12.56%-65.78M | ---32.77M | -10.61%-58.44M | ---52.84M |
| Operating expenses | -14.03%-34.65M | 3.57%-63.43M | 7.27%-30.39M | -12.56%-65.78M | -32.77M | -10.61%-58.44M | -52.84M |
| Gross profit | -5.47%82.64M | -1.83%182.06M | -1.74%87.43M | 23.97%185.44M | 88.97M | 10.15%149.59M | 135.8M |
| Selling expenses | -35.34%-66.46M | 0.89%-105.65M | 6.45%-49.1M | -13.51%-106.6M | ---52.49M | -8.16%-93.91M | ---86.82M |
| Administrative expenses | -43.79%-26.75M | -25.99%-39.2M | -28.58%-18.6M | -20.40%-31.12M | ---14.47M | -22.79%-25.84M | ---21.05M |
| Special items of operating profit | 124.13%2.06M | -3,431.42%-17.39M | -7,403.42%-8.55M | -86.85%522K | --117K | 900.00%3.97M | --397K |
| Operating profit | -176.10%-8.5M | -58.94%19.81M | -49.52%11.17M | 42.73%48.25M | 22.13M | 19.33%33.81M | 28.33M |
| Financing cost | -21.71%-583K | -17.11%-1.14M | -4.81%-479K | 4.90%-970K | ---457K | -25.62%-1.02M | ---812K |
| Earning before tax | -184.96%-9.09M | -60.50%18.68M | -50.66%10.69M | 44.21%47.28M | 21.68M | 19.14%32.79M | 27.52M |
| Tax | 148.30%1.55M | 26.58%-5.71M | 5.00%-3.21M | -61.61%-7.78M | ---3.38M | -10.97%-4.81M | ---4.34M |
| After-tax profit from continuing operations | -200.69%-7.54M | -67.18%12.97M | -59.10%7.48M | 41.22%39.5M | 18.3M | 20.67%27.97M | 23.18M |
| Earning after tax | -200.69%-7.54M | -67.18%12.97M | -59.10%7.48M | 41.22%39.5M | 18.3M | 20.67%27.97M | 23.18M |
| Profit attributable to shareholders | -200.69%-7.54M | -67.18%12.97M | -59.10%7.48M | 41.22%39.5M | 18.3M | 20.67%27.97M | 23.18M |
| Basic earnings per share | -175.53%-0.0565 | -67.54%0.1282 | 0.0748 | 0.395 | |||
| Diluted earnings per share | -175.53%-0.0565 | -67.54%0.1282 | 0.0748 | 0.395 | |||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.